Cargando…

Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma

The treatment outcome of hepatocellular carcinoma (HCC) is severely hampered due to its etiology, and thus in depth understanding of the genetic mechanisms underlying response of HCC to various anticancer agents is needed. Here, we have identified Phosphotyrosine interaction domain-containing protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jian, Li, Senlin, He, Jialuo, Xu, Qianqian, Xie, Mengyuan, Yang, Ci, Wang, Hongjie, Zhang, Yonghui, Wan, Qian, Xiang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147665/ https://www.ncbi.nlm.nih.gov/pubmed/37117198 http://dx.doi.org/10.1038/s41420-023-01405-1

Ejemplares similares

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling
por: Bao, Fan, et al.
Publicado: (2023)

Pattern recognition and PID for COMPASS RICH-1
por: Abbon, P., et al.
Publicado: (2009)

CFHBA-PID Algorithm: Dual-Loop PID Balancing Robot Attitude Control Algorithm Based on Complementary Factor and Honey Badger Algorithm
por: Lin, Jianan, et al.
Publicado: (2022)

PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
por: Yin, Chunyan, et al.
Publicado: (2019)

CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways
por: Al Shahrani, Mesfer, et al.
Publicado: (2022)

AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf & TSC1/TSC2
por: Lin, Hui-Ping, et al.
Publicado: (2015)

PID_TUNE: A PID Autotuning Software Tool on UNICOS CPC
por: Blanco Vinuela, Enrique, et al.
Publicado: (2015)

Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
por: Yin, Chunyan, et al.
Publicado: (2019)

LHCb reconstruction and PID
por: Santana Rangel, Murilo
Publicado: (2020)

Advanced PID control
por: Astrom, Karl J, et al.
Publicado: (2006)

Advances in PID control
por: Tan Kok Kiong, et al.
Publicado: (1999)

Raf-1 regulates migration
por: Tuma, Rabiya S.
Publicado: (2005)

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2016)

IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways
por: Cai, Wenpeng, et al.
Publicado: (2023)

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway
por: Li, Xuguang, et al.
Publicado: (2020)

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation
por: Yuan, Jingsheng, et al.
Publicado: (2022)

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways
por: Chen, Shi‐Lu, et al.
Publicado: (2019)

Cooperative Effects of Akt-1 and Raf-1 on the Induction of Cellular Senescence in Doxorubicin or Tamoxifen Treated Breast Cancer Cells
por: Taylor, Jackson R., et al.
Publicado: (2011)

Pelvic Inflammatory Disease (PID)
por: Soper, David E.
Publicado: (1996)

PID: the Pathway Interaction Database
por: Schaefer, Carl F., et al.
Publicado: (2009)

Process identification and PID control
por: Sung, Su Whan, et al.
Publicado: (2009)

Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling
por: Zheng, Wei, et al.
Publicado: (2022)

The ALICE PID performance in Run 1 and perspectives in view of Run 2
por: Noferini, Francesco
Publicado: (2016)

Optogenetic clustering of CNK1 reveals mechanistic insights in RAF and AKT signalling controlling cell fate decisions
por: Fischer, Adrian, et al.
Publicado: (2016)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

The PID Life Index: an interactive tool to measure the status of the PID healthcare environment in any given country
por: Solís, Leire, et al.
Publicado: (2022)

Protein and lipid kinase inhibitors as targeted anticancer agents of the Ras/Raf/MEK and PI3K/PKB pathways
por: García-Echeverría, Carlos
Publicado: (2008)

Three distinct regions of cRaf kinase domain interact with membrane
por: Prakash, Priyanka, et al.
Publicado: (2019)

Report from the ALICE PID panel
por: Klanner, Robert, et al.
Publicado: (1998)

PID performance in Run 2 at LHCb
por: Seuthe, Alex
Publicado: (2021)

Faddeev calculations of $\piD$ scattering
por: Thomas, A W
Publicado: (1976)

PID performance in Run 2 at LHCb
por: Seuthe, Alex
Publicado: (2020)

PID performance in Run2 at LHCb
por: Seuthe, Alex
Publicado: (2020)

LHCb: tracking and flavour-tagging and PID
por: Lisovskyi, Vitalii
Publicado: (2021)

Connected Research: The Potential of the PID Graph
por: Cousijn, Helena, et al.
Publicado: (2021)

Fuzzy PID Control for Respiratory Systems
por: Mehedi, Ibrahim M., et al.
Publicado: (2021)

Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023)

The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index
por: Nordin, Julia, et al.
Publicado: (2021)

Raf-1 sheds then spreads its inhibitions
por: Short, Ben
Publicado: (2009)

Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer
por: Kizilboga, Tugba, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nesdo9l60r9gd6lii5ujo0ih3f